| Pharmaceutical active ingredients: |
| Benserazide HydrochlorideLevodopa |
| Available forms, composition and doses of Levobens: |
| N / A |
| Levobens medical category: |
| Human:Antiparkinsonian drugsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Viatris |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cenparkin | Benserazide Hydrochloride; Levodopa | Charoen Bhaesaj |
| Co-Beneldopa | Benserazide Hydrochloride; Levodopa | Unidentified Pharmaceutical Company |
| Dopamed | Benserazide Hydrochloride; Levodopa | Dr. Kolassa & Merz |
| Leparson | Benserazide Hydrochloride; Levodopa | Dexa Medica Pharm & Chem |
| Levazide | Benserazide Hydrochloride; Levodopa | Pyridam |
| Levodopa Comp. B | Benserazide Hydrochloride; Levodopa | Stada |
| Levopar Plus | Benserazide Hydrochloride; Levodopa | Teva |
| Madopar | Benserazide Hydrochloride; Levodopa | Roche; DKSH; Firma Chun Cheong; Zentiva; Zuellig Pharma |
| Madopar CR | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar Depot | Benserazide Hydrochloride; Levodopa | Roche |